Sarepta Therapeutics: Strong Buy Rating Amid Strategic Partnership and Promising Growth ...
Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kostas ...